Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis
Drew J.B. Kurtzman(Harvard University), Natalie A. Wright(Brigham and Women's Hospital), Janice Lin(Harvard University), Alisa N. Femia(Brigham and Women's Hospital), Joseph F. Merola(Harvard University), Mital Patel(Harvard University), Ruth Ann Vleugels(Harvard University)
Cited by 133Open Access
Abstract
Dermatomyositis is an uncommon autoimmune disorder with distinctive cutaneous manifestations that are frequently challenging to manage. Although a number of therapies including hydroxychloroquine, methotrexate, mycophenolate mofetil, and intravenous immunoglobulin have demonstrated efficacy, few alternative treatments are available when these agents fail.
Related Papers
No related papers found
Powered by citation graph analysis